Cargando…
Telomerase activation in nasopharyngeal carcinomas.
Nasopharyngeal carcinomas (NPC) are common in Hong Kong and southern China but rare in Western countries. Telomerase activation is common in human cancers but has not been reported previously in NPC. Telomerase activation in NPC was determined using the sensitive TRAP (telomerase rapid amplification...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151288/ https://www.ncbi.nlm.nih.gov/pubmed/9472643 |
_version_ | 1782144717354434560 |
---|---|
author | Cheng, R. Y. Yuen, P. W. Nicholls, J. M. Zheng, Z. Wei, W. Sham, J. S. Yang, X. H. Cao, L. Huang, D. P. Tsao, S. W. |
author_facet | Cheng, R. Y. Yuen, P. W. Nicholls, J. M. Zheng, Z. Wei, W. Sham, J. S. Yang, X. H. Cao, L. Huang, D. P. Tsao, S. W. |
author_sort | Cheng, R. Y. |
collection | PubMed |
description | Nasopharyngeal carcinomas (NPC) are common in Hong Kong and southern China but rare in Western countries. Telomerase activation is common in human cancers but has not been reported previously in NPC. Telomerase activation in NPC was determined using the sensitive TRAP (telomerase rapid amplification protocol) assay in 45 nasopharyngeal biopsies (36 NPC, nine normal nasopharyngeal mucosae) in four xenografted NPC tumours established in nude mice and in five in vitro NPC cell lines. Telomerase activation is common in NPC and can be detected at high frequencies (85% in primary tumours and 100% in recurrent tumours). The frequency of telomerase activation was lowest in NPC biopsies without lymph node involvement (60%) compared with those with positive lymph node involvement (100%), and the difference is statistically significant (P < 0.05; Fisher exact test). All the xenografted NPC tumours and in vitro NPC cell lines were strongly positive for telomerase activity. Our results suggest that telomerase activation is common in NPC and it may be useful as a diagnostic marker in the detection of tumour cells in nasopharyngeal biopsies. The high frequency of telomerase activation in stage I NPC (80% positive) suggests that it is an early event in tumour progression. IMAGES: |
format | Text |
id | pubmed-2151288 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1998 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-21512882009-09-10 Telomerase activation in nasopharyngeal carcinomas. Cheng, R. Y. Yuen, P. W. Nicholls, J. M. Zheng, Z. Wei, W. Sham, J. S. Yang, X. H. Cao, L. Huang, D. P. Tsao, S. W. Br J Cancer Research Article Nasopharyngeal carcinomas (NPC) are common in Hong Kong and southern China but rare in Western countries. Telomerase activation is common in human cancers but has not been reported previously in NPC. Telomerase activation in NPC was determined using the sensitive TRAP (telomerase rapid amplification protocol) assay in 45 nasopharyngeal biopsies (36 NPC, nine normal nasopharyngeal mucosae) in four xenografted NPC tumours established in nude mice and in five in vitro NPC cell lines. Telomerase activation is common in NPC and can be detected at high frequencies (85% in primary tumours and 100% in recurrent tumours). The frequency of telomerase activation was lowest in NPC biopsies without lymph node involvement (60%) compared with those with positive lymph node involvement (100%), and the difference is statistically significant (P < 0.05; Fisher exact test). All the xenografted NPC tumours and in vitro NPC cell lines were strongly positive for telomerase activity. Our results suggest that telomerase activation is common in NPC and it may be useful as a diagnostic marker in the detection of tumour cells in nasopharyngeal biopsies. The high frequency of telomerase activation in stage I NPC (80% positive) suggests that it is an early event in tumour progression. IMAGES: Nature Publishing Group 1998 /pmc/articles/PMC2151288/ /pubmed/9472643 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Cheng, R. Y. Yuen, P. W. Nicholls, J. M. Zheng, Z. Wei, W. Sham, J. S. Yang, X. H. Cao, L. Huang, D. P. Tsao, S. W. Telomerase activation in nasopharyngeal carcinomas. |
title | Telomerase activation in nasopharyngeal carcinomas. |
title_full | Telomerase activation in nasopharyngeal carcinomas. |
title_fullStr | Telomerase activation in nasopharyngeal carcinomas. |
title_full_unstemmed | Telomerase activation in nasopharyngeal carcinomas. |
title_short | Telomerase activation in nasopharyngeal carcinomas. |
title_sort | telomerase activation in nasopharyngeal carcinomas. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151288/ https://www.ncbi.nlm.nih.gov/pubmed/9472643 |
work_keys_str_mv | AT chengry telomeraseactivationinnasopharyngealcarcinomas AT yuenpw telomeraseactivationinnasopharyngealcarcinomas AT nichollsjm telomeraseactivationinnasopharyngealcarcinomas AT zhengz telomeraseactivationinnasopharyngealcarcinomas AT weiw telomeraseactivationinnasopharyngealcarcinomas AT shamjs telomeraseactivationinnasopharyngealcarcinomas AT yangxh telomeraseactivationinnasopharyngealcarcinomas AT caol telomeraseactivationinnasopharyngealcarcinomas AT huangdp telomeraseactivationinnasopharyngealcarcinomas AT tsaosw telomeraseactivationinnasopharyngealcarcinomas |